|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.83 USD | -0.23% |
|
+0.03% | +12.85% |
| Dec. 16 | Harmony Biosciences, Beacon Biosignals Collaborate on Phase 3 Trials in Narcolepsy, Hypersomnia | MT |
| Dec. 16 | Beacon Biosignals announces partnership with Harmony Biosciences | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- HRMY Stock
- Consensus Harmony Biosciences Holdings, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
